Search

Your search keyword '"Sando, Sigrid B."' showing total 167 results

Search Constraints

Start Over You searched for: Author "Sando, Sigrid B." Remove constraint Author: "Sando, Sigrid B."
167 results on '"Sando, Sigrid B."'

Search Results

1. Beyond the Global Brain Differences: Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers

2. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

3. New insights into the genetic etiology of Alzheimer’s disease and related dementias

4. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease

5. Beyond the Global Brain Differences:Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers

6. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

7. Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

8. Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease

9. Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease

10. C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

11. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

12. Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease

13. GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

14. Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci

15. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

16. Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

17. Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer’s Disease in Nordic Populations

18. Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations

19. Evidence for an association between KIBRA and late-onset Alzheimer's disease

22. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

23. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

24. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

25. Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies

26. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

27. Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition

28. Correction : Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia (Molecular Psychiatry, (2020), 25, 3, (584-602), 10.1038/s41380-018-0118-1)

29. Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2)

30. GBA and APOE epsilon 4 associate with sporadic dementia with Lewy bodies in European genome wide association study

31. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk

32. Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications

33. Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

35. Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study

36. APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway

37. Genetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimer’s disease risk

39. Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease

42. Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study

43. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer’s Disease

44. Erratum to : Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility

45. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease

46. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease

47. LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)

48. Fine-mapping and candidate gene investigation within the PARK10 locus

50. Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility.

Catalog

Books, media, physical & digital resources